Reporting Standards for Uterine Artery Embolization for the Treatment of Uterine Leiomyomata

Journal of Vascular and Interventional Radiology

Volumn 14, Issue 9 PART 2, 2003, Pages

  Goodwin, Scott C ^a   Bonilla, Sheila C ^a   Sacks, David ^a   Reed, Richard A ^a   Spies, James B ^a   Landow, Wendy J ^a   Worthington Kirsch, Robert L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 30344436235     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000094620.61428.9c     Document Type: Article

References (43)

1. Sampson J.A. The blood supply of uterine myomata. Surg Gynecol Obstet 14 (1912) 215-230
2. Goodwin S.C., Vedantham S., McLucas B., et al. Preliminary experience with uterine artery embolization for uterine fibroids. J Vasc Interv Radiol 8 (1997) 517-526
3. Worthington-Kirsch R.L., Popky G.L., and Hutchins F.L. Uterine arterial embolization for the management of leiomyomas: quality-of-life assessment and clinical response. Radiology 208 (1998) 625-629
4. Siskin G., Eaton L., Stainken B., Dowling K., Herr A., and Schwartz J. Pathologic findings in a uterine leiomyoma after bilateral uterine artery embolization. J Vasc Interv Radiol 10 (1999) 891-894
5. Ravina J.H., Herbreteau D., Ciraru-Vigneron N., et al. Arterial embolisation to treat uterine myomata. Lancet 346 (1995) 671-672
6. Bradley E.A., Reidy J.F., Forman R.G., Jarosz J., and Braude P.R. Transcatheter uterine artery embolisation to treat large uterine fibroids. Br J Obstet Gynaecol 105 (1998) 235-240
7. Ravina J.H., Bouret J.H., Ciraru-Vigneron N., et al. Recourse to particular arterial embolization in the treatment of some uterine leiomyoma. Bull Fr Natl Acad Med 181 (1997) 233-243
8. Ravina J.H., Merland J.J., Ciraru-Vigneron N., et al. Arterial embolization: a new treatment of menorrhagia in uterine fibroma [letter]. Presse Med 24 (1995) 1754
9. Hutchins F.L., Worthington-Kirsch R., and Berkowitz R.P. Selective uterine artery embolization as primary treatment for symptomatic leiomyomata uteri. J Am Assoc Gynecol Laparos 6 (1999) 279-284
10. Goodwin S.C., McLucas B., Lee M., et al. Uterine artery embolization for the treatment of uterine leiomyomata: midterm results. J Vasc Interv Radiol 10 (1999) 1159-1165
11. Spies J.B., Scialli A.R., Jha R.C., et al. Initial results from uterine fibroid embolization for symptomatic leiomyomata. J Vasc Interv Radiol 10 (1999) 1149-1157
12. Vollenhoven B.J., Lawrence A.S., and Healy D.L. Uterine fibroids: a clinical review. Br J Obstet Gyn 97 (1990) 285-298
13. Smith S.J., Sewall L.E., and Handelsman A. A clinical failure of uterine fibroid embolization due to adenomyosis. J Vasc Interv Radiol 10 (1999) 1171-1174
14. ACOG Committee on Practice Bulletins-Gynecology, and Stewart E.A. Clinical management guidelines for obstetrician-gynecologists: surgical alternatives to hysterectomy in the management of leiomyomas. ACOG Prac Bull (2000) 16
15. Arnold L.L., Ascher S.M., Schruefer J.J., et al. The nonsurgical diagnosis of adenomyosis. Obstet Gynecol 86 (1995) 461-465
16. Togashi K., Ozasa H., Konishi I., et al. Enlarged uterus: differentiation between adenomyosis and leiomyoma with MR imaging. Radiology 171 (1989) 531-534
17. Imaoka I., Sugimura K., Masui T., et al. Abnormal uterine cavity: differential diagnosis with MR Imaging. Magn Reson Imaging 17 (1999) 1445-1455
18. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF- 36). I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
19. Kim J., Spies J.B., Zorn J.G., Roth A.R., and Walsh S.M. Use of the SF-12 health survey for general health status assessment after uterine fibroid embolization: preliminary findings [abstract]. J Vasc Interv Radiol 11 suppl (2000) 309
20. Carlson K.J., Miller B.A., and Fowler F.J. The Maine Women's Health Study. I. Outcomes of hysterectomy. Obstet Gynecol 83 (1994) 556-655
21. Coulter A., Peto V., and Jenkinson C. Quality of life and patient satisfaction following treatment for menorrhagia. Fam Pract 11 (1994) 394-401
22. Spies J.B., Warren E.H., Mathias S.D., et al. Uterine fibroid embolization: measurement of health-related quality of life before and after therapy. J Vasc Interv Radiol 10 (1999) 1293-1303
23. Coyne K, Sasane M, Walsh SM, Spies JB. Developing a symptom and health-related quality of life questionnaire for uterine fibroids. Presented at: The 7th Annual Conference of the International Society for Quality of Life Research; October 29-31, 2000; Vancouver, BC, Canada.
24. Higham J.M., O'Brien P.M.S., and Shaw R.W. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 97 (1990) 734-739
25. Janssen C.A., Scholten P.C., and Heintz A.P. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet Gynecol 85 (1995) 977-982
26. Ruta D., Garratt A., Chadha Y., et al. Assessment of patients with menorrhagia: how valid is a structured clinical history as a measure of health status?. Qual Life Res 4 (1995) 33-40
27. Katz R.N., Mitty H.A., Stancata-Pasik A., Cooper J.M., and Ahn J. Comparison of uterine artery embolization for fibroids using gelatin sponge pledgets and polyvinyl alcohol [abstract]. J Vasc Interv Radiol 9 suppl (1998) 184
28. Nikolic B., Spies J.B., Abbara S., and Goodwin S.C. Ovarian artery supply of uterine fibroids as a cause of treatment failure after uterine artery embolization: a case report. J Vasc Interv Radiol 10 (1999) 1167-1170
29. Pelage J.P., Le Dref O., Soyer P., et al. Arterial anatomy of the female genital tract: variations and relevance to transcatheter embolization of the uterus. AJR Am J Roentgenol 172 (1999) 989-994
30. Nikolic B., Spies J.B., Lundsten M.J., and Abbara S. Patient radiation dose associated with uterine artery embolization. Radiology 214 (2000) 121-125
31. McDermott V.G., Schuster M.G., and Smith T.P. Antibiotic prophylaxis in vascular and interventional radiology. AJR Am J Roentgenol 169 (1997) 31-38
32. Roth A.R., Spies J.B., Walsh S.M., Wood B.J., Gomez-Jorge J., and Levy E.B. Pain after uterine artery embolization for leiomyomata: can its severity be predicted and does severity predict outcome?. J Vasc Interv Radiol 11 (2000) 1047-1052
33. Peto R., Pike M.C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 34 (1976) 585-612
34. Speroff L., Glass R., and Kase N. Clinical gynecologic endocrinology and infertility. 5th ed. (1994), Williams & Wilkins, Baltimore, MD 813-814
35. Aiman J., and Smentek C. Premature ovarian failure. Obstet Gynecol 66 (1985) 9-14
36. Rebar R.W., Erckson G.F., and Yen S.S.C. Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil Steril 37 (1982) 35-41
37. Vashisht A., Studd J., Carey A., and Burn P. Fatal septicaemia after fibroid embolisation. Lancet 354 (1999) 307-308
38. Lanocita R, Frigerio LF, Patelli G, Di Tolla G, Spreafico C. A fatal complication of percutaneous transcatheter embolization for treatment of uterine fibroids. Presented at the 2nd International Symposium on Embolization of Uterine Myomata. The Society for Minimally Invasive Therapy/Center for Innovative Minimally Invasive Therapy, 11th International Conference; Sept. 16-18, 1999; Boston, Mass.
39. Hemingway A.P. Complications of embolotherapy. In: Kadir S. (Ed). Current practice of interventional radiology (1991), Decker, Philadelphia 104-109
40. Yen S., Tsai C., Naftolin F., et al. Pulsatile patterns of gonadotropin release in subjects with and without ovarian function. J Clin Endocrinol Metab 34 (1972) 671-675
41. Sacks D., Marinelli D.L., Martin L.G., Spies J.B., and and the members of the Technology Assessment Committee. General principles for evaluation of new interventional technologies and devices. J Vasc Interv Radiol 8 (1997) 133-136
42. Goodwin S.C., Landow W.J., Matalon T.A., Mauro M.A., Pomerantz P., and Worthington-Kirsch R.L. Opportunity and responsibility: SCVIR's role with uterine artery embolization. J Vasc Interv Radiol 11 (2000) 409-410
43. Finkler S.A. The distinction between cost and charges. Ann Intern Med 96 (1982) 102-109